Teva to pay up to $4.2 billion in U.S. to settle opioid claims By Reuters


© Reuters. FILE PHOTO: A Teva Pharmaceutical Industries building is seen in Jerusalem December 14, 2017. REUTERS/Ammar Awad

(Reuters) – Teva Pharmaceuticals will pay up to $4.2 billion in the United States to settle claims related to its role in fueling the country’s opioid crisis, New York Attorney General Letitia James said on Thursday.

The company will pay $523 million to New York state to settle claims in the state, James said.

Be the first to comment

Leave a Reply

Your email address will not be published.


*